POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Seq. Identity (%)	View	Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JQZ_A_LQZA586_1 (SERUM ALBUMIN)	1tf0	SERUM ALBUMIN (Homo sapiens)	4 / 6	ASP A 187 LYS A 190 ARG A 428 LYS A 432	None	1.15A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TTR_A_LQZA90_1 (LACTOTRANSFERRIN)	1dhs	DEOXYHYPUSINE SYNTHASE (Homo sapiens)	3 / 3	PRO A 203 THR A 202 LEU A 265	None	0.68A	21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TTR_A_LQZA90_1 (LACTOTRANSFERRIN)	1eqf	RNA POLYMERASE II TRANSCRIPTION INITIATION FACTOR (Homo sapiens)	3 / 3	PRO A1404 THR A1402 LEU A1427	None	0.75A	21.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TTR_A_LQZA90_1 (LACTOTRANSFERRIN)	1ni6	HEME OXYGENASE 1 (Homo sapiens)	3 / 3	PRO A 109 THR A 108 LEU A 213	None	0.70A	20.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TTR_A_LQZA90_1 (LACTOTRANSFERRIN)	2d86	VAV-3 PROTEIN (Homo sapiens)	3 / 3	PRO A 126 THR A 125 LEU A  57	None	0.74A	14.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TTR_A_LQZA90_1 (LACTOTRANSFERRIN)	2j9l	CHLORIDE CHANNEL PROTEIN 5 (Homo sapiens)	3 / 3	PRO A 675 THR A 676 LEU A 669	None	0.72A	19.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TTR_A_LQZA90_1 (LACTOTRANSFERRIN)	3ebb	PHOSPHOLIPASE A2-ACTIVATING PROTEIN (Homo sapiens)	3 / 3	PRO A 591 THR A 592 LEU A 575	None	0.77A	20.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TTR_A_LQZA90_1 (LACTOTRANSFERRIN)	3ojy	COMPLEMENT COMPONENT C8 ALPHA CHAIN (Homo sapiens)	3 / 3	PRO A  36 THR A 483 LEU A  11	None	0.75A	19.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TTR_A_LQZA90_1 (LACTOTRANSFERRIN)	3t5o	COMPLEMENT COMPONENT C6 (Homo sapiens)	3 / 3	PRO A  88 THR A 516 LEU A  63	None	0.67A	16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TTR_A_LQZA90_1 (LACTOTRANSFERRIN)	4f9o	HEXOKINASE-1 (Homo sapiens)	3 / 3	PRO A 115 THR A 114 LEU A 126	None	0.69A	17.07